Abstract
HIV-1 integrase (IN) is a crucial enzyme in the life cycle of HIV-1 and also a validated target for developing anti-HIV inhibitors. Recent progress in drug design has significantly accelerated the development of anti-AIDS IN inhibitors. A large amount of novel inhibitors that interact specifically with IN were developed along with the expanding and application of methods to drug design. This article reviewed the anti-HIV IN inhibitors discovered by the rational drug design approaches in the recent 5-year.
Keywords: de novo drug design, HIV, integrase inhibitors, ligand-based drug design, pharmacophore, receptor-based drug design, virtual screening, Genetic Algorithms, DOCK
Mini-Reviews in Medicinal Chemistry
Title:Perspectives on Developing Small Molecule Inhibitors Targeting HIV-1 Integrase
Volume: 12 Issue: 9
Author(s): J. J. Tan, C. Liu, X. H. Sun, X. J. Cong, L. M. Hu, C. X. Wang and X. J. Liang
Affiliation:
Keywords: de novo drug design, HIV, integrase inhibitors, ligand-based drug design, pharmacophore, receptor-based drug design, virtual screening, Genetic Algorithms, DOCK
Abstract: HIV-1 integrase (IN) is a crucial enzyme in the life cycle of HIV-1 and also a validated target for developing anti-HIV inhibitors. Recent progress in drug design has significantly accelerated the development of anti-AIDS IN inhibitors. A large amount of novel inhibitors that interact specifically with IN were developed along with the expanding and application of methods to drug design. This article reviewed the anti-HIV IN inhibitors discovered by the rational drug design approaches in the recent 5-year.
Export Options
About this article
Cite this article as:
J. Tan J., Liu C., H. Sun X., J. Cong X., M. Hu L., X. Wang C. and J. Liang X., Perspectives on Developing Small Molecule Inhibitors Targeting HIV-1 Integrase, Mini-Reviews in Medicinal Chemistry 2012; 12 (9) . https://dx.doi.org/10.2174/138955712800959107
DOI https://dx.doi.org/10.2174/138955712800959107 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
Call for Papers in Thematic Issues
Bioprospecting of Natural Products as Sources of New Multitarget Therapies
According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more
Computational Frontiers in Medicinal Chemistry
The thematic issue "Computational Frontiers in Medicinal Chemistry" provides a robust platform for delving into state-of-the-art computational methodologies and technologies that significantly propel advancements in medicinal chemistry. This edition seeks to amalgamate top-tier reviews spotlighting the latest trends and breakthroughs in the fusion of computational approaches, including artificial intelligence (AI) ...read more
Mitochondria as a Therapeutic Target in Metabolic Disorders
Mitochondria are the primary site of adenosine triphosphate (ATP) production in mammalian cells. Moreover, these organelles are an important source of reactive oxygen and nitrogen species in virtually any nucleated cell type. The modulation of a myriad of cellular signaling pathways depends on the mitochondrial physiology. Mitochondrial dysfunction is observed ...read more
Natural Products and Dietary Supplements in Alleviation of Metabolic, Cardiovascular, and Neurological Disorders
Metabolic disorders like diabetes, obesity, inflammation, oxidative stress, cancer etc, cardiovascular disorders like angina, myocardial infarction, congestive heart failure etc as well as neurological disorders like Alzheimer?s, Parkinson?s, Epilepsy, Depression, etc are the global burden. They covered the major segment of the diseases and disorders from which the human community ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Review of the Psychometric Properties of the CRAFFT Instrument: 1999-2010
Current Drug Abuse Reviews Myocardial Energetics in Left Ventricular Hypertrophy
Current Cardiology Reviews Important Hints in Behavioural Teratology of Rodents
Current Pharmaceutical Design Vitamin D Biology in Heart Failure: Molecular Mechanisms and Systematic Review
Current Drug Targets Therapeutic Application of Histone Deacetylase Inhibitors for Stroke
Central Nervous System Agents in Medicinal Chemistry Amyloid-β Oligomers-induced Mitochondrial DNA Repair Impairment Contributes to Altered Human Neural Stem Cell Differentiation
Current Alzheimer Research Targeted Delivery of Anti-Inflammatory Agents to Tumors
Current Pharmaceutical Design The TNF-α System: Functional Aspects in Depression, Narcolepsy and Psychopharmacology
Current Neuropharmacology Multifaceted Individualities in Pharmacological Treatments of Obesity
Current Clinical Pharmacology Molecular Strategies for the Treatment of Huntingtons Disease
Current Pharmacogenomics Drug Metabolism and Pharmacokinetics in Support of Drug Design
Current Pharmaceutical Design In Vitro Metabolism Studies of New Adenosine A Receptor Antagonists
Drug Metabolism Letters Current Status and Future Prospects of C1 Domain Ligands as Drug Candidates
Current Topics in Medicinal Chemistry Immunomodulatory Activity of MicroRNAs: Potential Implications for Multiple Myeloma Treatment
Current Cancer Drug Targets Somatic Treatments Excluding Psychopharmacology in Obsessive- Compulsive Disorder: A Review.
Reviews on Recent Clinical Trials The Need for Physiologically Relevant Peroxisome Proliferator-Activated Receptor-gamma (PPAR-γ) Ligands
Endocrine, Metabolic & Immune Disorders - Drug Targets Preface: Recent Innovation in Chemical Engineering Based on Advanced Materials
Recent Innovations in Chemical Engineering Editorial [Hot Topic: The Medicinal Chemistry of Hybrid-Based Drugs Targeting Multiple Sites of Action (Guest Editors: Jose Marco-Contelles, & Elena Soriano)]
Current Topics in Medicinal Chemistry SELDI Protein Chip Technology for the Detection of Serum Biomarkers for Liver Disease
Protein & Peptide Letters Vilazodone Hydrochloride Multi-dose Nasal Spray Solution for the Treatment of Depression: Design, Optimization and Evaluation
Current Drug Therapy